Therapeutic Response Monitoring with (89)Zr-DFO-Pertuzumab in HER2-Positive and Trastuzumab-Resistant Breast Cancer Models

Immuno-positron emission tomography (PET) has great potential to evaluate the target expression level and therapeutic response for targeted cancer therapy. Immuno-PET imaging with pertuzumab, due to specific recognition in different binding sites of HER2, could be useful for the determination of the...

Descripción completa

Detalles Bibliográficos
Autores principales: Kang, Minwoo, Shin, Jong Il, Han, Sangjin, Kim, Jung Young, Park, Jeonghoon, Kim, Kwang Il, Kang, Joo Hyun, Lee, Tae Sup
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9324044/
https://www.ncbi.nlm.nih.gov/pubmed/35890234
http://dx.doi.org/10.3390/pharmaceutics14071338

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9324044/
https://www.ncbi.nlm.nih.gov/pubmed/35890234
http://dx.doi.org/10.3390/pharmaceutics14071338

Ejemplares similares